Ah it feels like khal works in the enablement team. Provides ample documentation but minimal or nobody actually reads it and you get asked questions where you want to just refer them back to the documentation lol.
I like the breakdown here dude thanks for that. I’ll have to see if I got any stakeholder rewards that would be neat.
The breakdown for content and ads seems like it will be a good thing in the long run. Pretty rad that we are aiming towards a community vote on an ad. Could you imagine how hard the pharma companies would get fucking vetoed lol